Excited to share our latest publication on demographic & geographic diversity in axial spondyloarthritis drug trials! We analyzed 59 trials (16,000+ participants) since 2000. Big thanks to the team @wissamghusn.bsky.social @spondymd.bsky.social @joergermann pubmed.ncbi.nlm.nih.gov/40089303/
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region - PubMed
The enrollment of women in axSpA drug trials largely reflects disease demographics. Race and ethnicity reporting has improved over time. While participation of Asian, American Indian/Alaska Native and...
pubmed.ncbi.nlm.nih.gov
